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Background: Assisted reproduction technology offers the opportunity to observe the very 40 
early stages of human development. However, due to practical constraints, for decades 41 
morphological examination of embryo development has been undertaken at a few isolated 42 
time points at the stages of fertilisation (day 1), cleavage (day 2-3) and blastocyst (day 5-6). 43 
Rather surprisingly, the morula stage (day 3-4) has been so far neglected, despite its 44 
involvement in crucial cellular processes and developmental decisions.  45 
 46 
Objective and rationale: The objective of this review is to collate novel and unsuspected 47 
insights into developmental processes occurring during formation of the morula, highlighting 48 
the key importance of this stage for a better understanding of preimplantation development 49 
and an improvement of ART.  50 
 51 
Search method: PubMed was used to search the MEDLINE database for peer-reviewed 52 
English-language original articles and reviews concerning the morula stage in mammals. 53 
Searches were performed by adopting ‘embryo’, ‘morula’, ‘compaction’, ‘cell fate’ and 54 
‘IVF/assisted reproduction’ as main terms, in association with other keywords expressing 55 
concepts relevant to the subject (e.g. cell polarity). The most relevant publications, i.e. those 56 
concerning major phenomena occurring during formation of the morula in established 57 
experimental models and the human species, were assessed and discussed critically. 58 
 59 
Outcomes: Novel live cell imaging technologies and cell biology studies have extended our 60 
understanding of morula formation as a key stage for the development of the blastocyst and  61 
determination of the inner cell mass (ICM) and the trophectoderm (TE). Cellular processes, 62 
such as dynamic formation of filopodia and cytoskeleton-mediated zippering cell-to-cell 63 
interactions, intervene to allow cell compaction (a geometrical requisite essential for 64 
development) and formation of the blastocoel, respectively. At the same time, differential 65 
orientation of cleavage planes, cell polarity and cortical tensile forces interact and cooperate 66 
to position blastomeres either internally or externally, thereby influencing their cellular fate. 67 
Recent time lapse microscopy (TLM) observations also suggest that in the human the 68 
process of compaction may represent an important checkpoint for embryo viability, through 69 
which chromosomally abnormal blastomeres are sensed and eliminated by the embryo. 70 
 71 
Wider implications: In clinical embryology, the morula stage has been always perceived 72 
as a ‘black box’ in the continuum of preimplantation development. This has dictated its virtual 73 
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exclusion from mainstream ART procedures. Recent findings described in this review 74 
indicate that the morula, and the associated process of compaction, as a crucial stage not 75 
only for the formation of the blastocyst, but also for the health of the conceptus. This 76 
understanding may open new avenues for innovative approaches to embryo manipulation, 77 
assessment and treatment.  78 
 79 
 80 
Keywords: morula; compaction; embryo; inner cell mass; trophectoderm.  81 




In assisted reproduction technology (ART), embryos are routinely assessed and selected 84 
for transfer at isolated time points on day 2, 3 and, in case of culture to the blastocyst stage, 85 
day 5/6. Embryos may also be observed, but are rarely selected, on day 4, since embryo 86 
transfer (ET) at this stage does not imply the practical advantages of transfer on days 2-3 87 
(reduced costs and management) or day 5/6 (higher self-selection and increased cycle 88 
efficiency). Day 4 ET is also hindered by difficulties in assessing accurately the morphology 89 
of embryos at this stage of development. 90 
 91 
In normal undisturbed development, day 4 embryos have already started, and have often 92 
completed, the transition from the cleavage stages, in which blastomeres appear as well-93 
distinct approximately spherical units, to the compacted morula stage, characterised instead 94 
by tightly interconnected cells with ill-defined margins, localised either internally or externally 95 
in the embryo (ESHRE Atlas of Human Embryology). At the sub-cellular level, this phase of 96 
development is also when the blastomeres undergo cell polarisation. Cells localised 97 
internally are characterised by a nucleus positioned approximately centrally and organelles 98 
and other specialised structures distributed in the cell environment without an apparent 99 
pattern. Cells distributed externally respond instead to a more defined pattern: the nucleus 100 
is positioned basally, cell adhesion structures and stable acetylated microtubules are 101 
localised baso-laterally, while more dynamic microtubules, actin filaments and microvilli are 102 
found in the apical region. The regulation of the process of polarisation remains unclear, 103 
with significant efforts on unpicking the origin of cell polarity in mammalian embryos. 104 
Furthermore, the chromosomal status of the day 4 embryo has received little attention, 105 
despite the hypothesis that during development from the cleavage to the blastocyst stage, 106 
mosaic embryos can implement mechanisms of self-correction to reduce the aneuploidy 107 
load.  108 
 109 
Being a developmental phase less amenable to observation and morphological 110 
classification, knowledge of the human embryo on day 4 is limited compared to other stages 111 
of development, especially concerning the relationship between morphology and 112 
developmental ability. Consequently, this review will highlight the relevance of the morula 113 
relative to developmental processes that occur during preimplantation development and 114 
discuss downstream implications of such processes for practices used in human ART.  115 
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 116 
Methods  117 
 118 
PubMed was systematically searched for peer-reviewed original articles and reviews 119 
identified by relevant keywords, such as ‘embryo’, ‘blastomere’, ‘morula’, ‘compaction’, 120 
‘blastocyst’, ‘blastocoel’, ‘cell fate’, ‘cell lineage’, ‘cell determination’, ‘cell polarity’, ‘cell 121 
junctions’, ‘IVF’, ‘assisted reproduction’, ‘inner cell mass’ and ‘trophectoderm’. Keywords 122 
were used in multiple and overlapping combinations in order to identify those publications 123 
strictly relevant to the morula. Additional studies were identified by thorough analysis of 124 
reference lists from relevant publications. The ‘English language’ limit was applied. The most 125 
relevant publications, i.e. those concerning major phenomena occurring during the 126 
developmental morula stage were assessed and discussed critically to offer a 127 
comprehensive description of the process bridging early segmentation and the blastocyst. 128 
Concerning animal studies, priority was given to publications relevant to species more 129 
consistently used as experimental models for the human.  130 
 131 
The morula stage in the continuum of preimplantation development 132 
 133 
The crucial phases of preimplantation development have been described in meticulous 134 
detail; days 1 (fertilisation and first cleavage), days 2-3 (second and third rounds of 135 
cleavage) and days 5-7 (blastocyst stage) of human development have been assessed 136 
morphologically in thousands of studies. In contrast, the morula stage has received 137 
astonishingly little attention, as illustrated by an authoritative source describing the morula 138 
simply as “an indistinguishable mass of cells on day 4 of development” (ESHRE Atlas of 139 
Human Embryology). In the human, compaction typically occurs usually between the 8- and 140 
10-cell stage, although sporadically can be observed as early as the 4-cell stage (Iwata et 141 
al., 2014). Qualitative assessment of the morula also appears rather vague; a “good quality 142 
morula” is defined as “composed of 16-32 blastomeres and all the blastomeres should be 143 
included in the compaction process” (ESHRE Atlas of Human Embryology). Exclusion of 144 
one or more cells from the compacted morula is thought to be associated with reduced 145 
developmental competence (Ebner et al., 2009). However, the morula remains poorly 146 
described. This is due in part to the lack of well-defined morphological markers that can be 147 
considered typical of this stage. In addition, compaction and formation of the morula are 148 
dynamic processes, difficult to assess in IVF routine practice if observation is carried out at 149 
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isolated time points. Nevertheless, overlooking this “Cinderella” stage of development is 150 
naïve, since recent data indicate that the morula is pivotal for blastocyst formation, 151 
establishment of the first cell lineages and, therefore, the entire developmental process. This 152 
role is underpinned by molecular, metabolic and cellular changes, which are temporally and 153 
spatially regulated, and a transition from a group of individual cells to a co-ordinated, 154 
responsive structure (Brison et al., 2014). Stage-specific modulations of gene expression 155 
and metabolism are indicative of such changes.  156 
 157 
The early stages of embryo development are largely under the molecular control of 158 
maternally-inherited mRNAs and regulatory proteins stockpiled throughout oogenesis. The 159 
function of genes, referred to as “maternal effect genes”, encoding for such regulators was 160 
initially ascertained in invertebrates and lower vertebrates, but knowledge of their action in 161 
mammals, including the human, is emerging (Condic, 2016). This initial maternal control of 162 
development is gradually superseded as the embryo expresses its own genes. The first 163 
studies in the human reported that embryonic genome activation (EGA) began at 4 to 8-cell 164 
stage (Braude et al., 1988), but details of the overall dynamics of gene expression during 165 
preimplantation development remained unclear for several years. More recently, 166 
sophisticated DNA technologies have revealed a more detailed and complex picture of EGA, 167 
which has relevance for the morula stage.  Briefly, we now know that the first signs of 168 
transcription in the human embryonic genome are detectable at the 2-cell stage, much 169 
earlier than previously thought. Notably, analysis of the whole preimplantation period 170 
showed that EGA occurs in a multiphasic fashion at designated stages: a pattern seen 171 
mirrored in a range of mammalians embryos (Svoboda et al., 2015). A major wave of 172 
transcription activation occurs at the 4-6 cell stage, involving mainly genes with a role in the 173 
translation machinery. This sets the stage for the two following and more extensive 174 
transcriptional bursts, which take place towards the end of day 3 of development (from the 175 
8-10 cell stage interval), i.e. shortly before compaction of the morula (Vassena et al., 2011). 176 
Many genes transcribed in these phases encode for proteins related to the metabolism of 177 
lipids, proteins, amino acids and carbohydrates. Embryo compaction is therefore preceded 178 
by changes in gene expression that are suggestive of major shifts in embryo metabolism. 179 
 180 
Indeed, it is well documented both in model species and the human that during 181 
preimplantation development, metabolism undergoes important phase-dependent 182 
modifications in response to specific requirements of the embryo (Leese, 2012). During the 183 
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early cleavage stages, the embryo is comparatively quiescent (Smith and Sturmey, 2013). 184 
Cell divisions occur at a moderate pace, net mass does not increase and most of the energy 185 
requirements are focused on general homeostatic functions, with limited need for 186 
biosynthetic processes. Consequently, metabolic needs, in terms of ATP during the 187 
cleavage stages, are satisfied largely from low levels of oxidation of pyruvate and lactate, 188 
which are abundantly present in the surrounding environment (Smith and Sturmey, 2013). 189 
In addition, a high ATP:ADP ratio negatively regulates the flux of glucose through the 190 
glycolytic pathway prior to compaction (Rozell et al., 1992). This picture changes in the 191 
second half of preimplantation development, corresponding to a period when gene 192 
transcription is more sustained, the rate of cell division increases and embryo mass 193 
increases. Importantly, considerable energy is invested in Na+/K+ ATPase, an enzyme 194 
needed for an active transport of those ions from the surrounding environment to intercellular 195 
spaces (Martin and Leese, 1999; Houghton et al., 2003). A high ion concentration in the 196 
intercellular space facilitates movement of water down a concentration gradient from the 197 
extraembryonic environment, leading ultimately to the formation of the blastocoel (Watson 198 
and Barcroft, 2001). The energy demands for such activities are satisfied by a marked 199 
increase in metabolic function.  The rate of oxygen consumption rises significantly, as a 200 
range of metabolic fuels including pyruvate, glutamine and fatty acids are oxidised 201 
(Houghton et al., 1996)(Thompson et al., 1996)(Houghton et al., 2003)(Sturmey and Leese, 202 
2003)(Lopes et al., 2005). In parallel, there is a marked, significant rise in glucose 203 
consumption via aerobic glycolysis (Gardner et al., 2001)(Krisher and Prather, 2012). 204 
Importantly, aerobic utilisation of glucose can support multiple biosynthetic pathways, as 205 
well as providing ATP (Krisher and Prather, 2012). In addition to aerobic glycolysis, the 206 
increased uptake of glucose is important for sustaining the Pentose Phosphate Pathway, 207 
essential for the provision of ribose sugars necessary for nucleotide synthesis (Smith and 208 
Sturmey, 2013). Crucially, genes whose products, such as the pyruvate dehydrogenase 209 
complex, functionally linking glycolysis to the activity of the oxidative TCA cycle, may be 210 
regulated at the transcriptional level and expressed in a timely fashion. Therefore, as the 211 
embryo evolves from a low-energy, low activity, almost automatic system to one that is 212 
highly energetic, highly proliferative and developmentally active, the morula stage 213 
represents a key regulatory landmark during which a pyruvate-based metabolism 214 
characterised by low oxidative levels gives way to a more active aerobic utilisation of 215 
glucose, combined with other metabolic fuels, in response to modified developmental needs. 216 
Unfortunately, detailed knowledge of metabolism of the morula per se is sparse, compared 217 
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to the wealth of data on cleavage and blastocyst stage embryos, mostly due to the 218 
challenges described above. 219 
 220 
Inner/outer cells and morula geometry 221 
 222 
During preimplantation development, the cells of the embryo make their first developmental 223 
decision, i.e. whether to contribute to the formation of the inner cell mass (ICM) or the 224 
trophectoderm (TE) of the blastocyst. After implantation, the former will develop mainly into 225 
the soma of the future organism, while the latter will give raise to extra-embryonic tissues 226 
supporting the embryo proper. Classical studies carried out in the mouse have suggested 227 
the concept (referred to as inside-outside theory) that, as cleavage progresses, blastomeres 228 
that become totally internalised within the structure of the embryo will exclusively form the 229 
ICM, while blastomeres that remain external and exposed to the surrounding environment 230 
will contribute mainly to the TE. These conclusions were drawn by simple, but ingenious, 231 
experiments in which outer cells of 16-cell mouse embryos were labelled with fluorescent 232 
microparticles and labelling patterns of ICM and TE were observed following development 233 
of morulae into blastocysts (Fleming, 1987). However, the precise timing and mechanism of 234 
the fate decision remains unclear and answers to the questions of how blastomeres acquire 235 
an inner or outer position, how inner and outer cells become different and how positional 236 
cues are translated into developmental decisions still elude us.  In a fascinating recent study, 237 
Biase et al. (2018) used an RNASeq approach, combined with cellular barcoding, to indicate 238 
that lineage differences were apparent as early as the two-cell stage in mouse embryos, 239 
indicating that the fate of the morula may be determined after the first cleavage. The morula 240 
and the process of compaction are particularly relevant to such questions, because they 241 
represent the functional manifestation of repositioning the inner and outer cells (as 242 
discussed below).    243 
 244 
The creation of the morula presents a geometrical challenge, in which cells are required to 245 
distinctly occupy internal or external positions. Up until the third round of divisions, all cells 246 
(up to eight) are approximately spherical and are all exposed to the surrounding 247 
environment, in addition to being in contact with each other. During the fourth round of 248 
cleavage, cell number increases from 8 to 16, and, on average, 5 blastomeres become 249 
positioned in the interior of the mouse embryo (Morris et al., 2010). If blastomeres were to 250 
retain a spherical shape and remain in mutual contact, for mere geometrical rules (the 251 
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Newton’s kissing number), only a single cell would find allocation internally in the embryo at 252 
the 13-cell stage (White et al., 2017). Beyond such a stage, the addition of further cells in 253 
the interior of the embryo would be impossible while maintaining blastomere and embryonic 254 
sphericity and cell-to-cell contact. In the mouse, compaction occurs normally between the 255 
8- and 16-cell stage, concomitantly with the formation of inner and outer cells. Cell 256 
compaction is therefore the geometrical, functionally-essential, solution that permits the 257 
development of populations of inner and outer cells in a definite proportion and to preserve 258 
its overall shape of a homogeneous sphere within the constraints of the zona pellucida. In 259 
the majority of cases in the human, compaction also occurs during the same developmental 260 
interval (Iwata et al., 2014), although the overall process of commitment of inner and outer 261 
cells in the formation of ICM and TE, respectively, is less certain (see below).   262 
 263 
The forces that shape the morula in the process of compaction 264 
 265 
Geometr is however only one of the several obstacles that the developing embryo has to 266 
overcome to ensure the generation of two cell lines. One of the most topical questions that 267 
concern the morula stage and indeed preimplantation development revolves around the 268 
forces that make compaction possible. Until the 8-cell stage, cleavage unfolds apparently 269 
uneventfully. Compaction marks a dramatic change in cell behaviour and shape, so 270 
profound that it can be observed by a simple transmitted light microscope. At compaction, 271 
blastomeres lose their sphericity to acquire a rather flattened epithelial-like shape in which 272 
cell contour is difficult to discriminate. This has prompted the hypothesis that cellular 273 
specialisations that ensure cell-to-cell contact and adhesion play an essential role in 274 
compaction. Early investigations on the Ca2+-dependent cell adhesion molecule E-cadherin 275 
were consistent with this hypothesis. In the mouse, E-cadherin is uniformly distributed in the 276 
cell membrane during the first cleavages but from the 8-cell stage, its localisation becomes 277 
restricted to intercellular adherens junctions, also referred to as zonulae adherens 278 
(Vestweber et al., 1987), which ensure mutual lateral adhesion between epithelial cells and 279 
contribute to the maintenance of epithelial cell polarity (Table 1). In the human, E-cadherin 280 
follows a similar pattern of redistribution, with a preferential localisation in adherens junctions 281 
from day 3.5-4.0 of development (Campbell et al., 1995). The initial finding that mouse 282 
compacted morulae exposed to functionally interfering anti-E-cadherin antibodies undergo 283 
decompaction (Vestweber and Kemler, 1985) inspired subsequent gene targeting studies. 284 
Indeed, mouse morulae homozygous for a null mutation of the E-cadherin-encoding gene 285 
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were unable to persist in a compacted state, progressively losing cohesiveness and 286 
reverting to a decompacted morphology, with cells still able to cleave but not mutually 287 
adhesive and unable to organise themselves into blastocyst (Riethmacher et al., 1995). One 288 
explanation for this is that the early embryo is endowed with E-cadherin molecules of 289 
maternal origin that can initiate compaction, but new, zygotic-derived E-cadherin is 290 
necessary to complete the process. Interestingly, loss of E-cadherin function and 291 
compaction is accompanied by intracellular alterations, particularly the loss of cell polarity 292 
(Riethmacher et al., 1995). However, compaction and cell polarity are not strictly mutually 293 
dependent because under specific experimental conditions, one process can occur in the 294 
absence of the other (Stephenson et al., 2010). 295 
 296 
In the mouse, other molecules interacting with E-cadherin in the formation of adherens 297 
junctions have been implicated in the process of compaction, further supporting a role for 298 
cell adhesion in this developmental phase. The intracellular domain of E-cadherin is 299 
connected with β- or γ-catenin. This complex is in contact with α-catenin, through which it is 300 
anchored to the actin cytoskeleton (Perez-Moreno et al., 2003). In mice, experimental 301 
ablation of α-catenin produces a phenotype similar to that of the previously described E-302 
cadherin null mutants, with embryos able to initiate but not complete compaction (Torres et 303 
al., 1997). By contrast, in β-catenin knockout embryos, compaction occurs unperturbed, with 304 
developmental anomalies emerging only at gastrulation, perhaps as an effect of redundancy 305 
due to the presence of other catenins or protracted action of maternal molecules (Haegel et 306 
al., 1995). Ephitin, a transmembrane serine protease, is another example of a cell adhesion 307 
molecule that appears to be involved in compaction. It co-localises with E-cadherin at areas 308 
of the cell membrane of contact between blastomeres of compacted mouse 8-cell embryos. 309 
When its expression is ablated in RNAi experiments, cell adhesion is lost and embryo death 310 
occurs shortly afterwards (Khang et al., 2005). Importantly, and unlike the mouse, the culture 311 
conditions may also affect the stability and function of junctional complexes occurring 312 
between blastomeres in human embryos, with implications for the process of compaction 313 
and ultimately embryo viability in vitro (Eckert et al., 2007). 314 
 315 
Recent advances in in-vivo labelling and time lapse imagining techniques have extended 316 
our understanding of the mechanisms of compaction and the role of E-cadherin and 317 
associated molecules. It is now possible to view E-cadherin distribution in live cells, by 318 
microinjecting RNA molecules encoding E-cadherin with a GFP fluorescent tag. This 319 
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approach has revealed a complex and regulated cell-to-cell interaction occurring at the time 320 
of compaction (Fierro-González et al., 2013). Before the 8-cell stage, E-cadherin is found 321 
throughout the cell membrane, although particularly abundant at adherens junctions. During 322 
the 8- to 16-cell stage interval, concomitant with compaction, E-cadherin-rich filopodia 323 
become visible. Originating from an area situated between the adherens junctions and the 324 
cell apical domain, these filopodia have a length of 10-12 µm and extend over the apical 325 
membrane of adjacent cells. These blastomere protrusions are positive for F-actin and 326 
Myo10, but do not appear to contain α-tubulin, consistent with typical filopodia structure 327 
(Table 1). Detailed 4D analysis during the 8- to 16-cell interval unveiled an astonishing 328 
regulation of filopodia (Fierro-González et al., 2013). They are detected only in 55-60% of 329 
all blastomeres. Each blastomere projects 5-6 filopodia over the apical membrane of 2-3 330 
adjacent cells; however, adjacent blastomeres never project filopodia reciprocally. Filopodia 331 
are dynamic, appearing to extend and retract in coordination with cell division. Remarkably, 332 
they are retracted before a cell division is initiated, while cells receiving filopodia do not 333 
divide as long as filopodia extend over their membranes. In addition, approximately two 334 
thirds of blastomeres with filopodia undergo symmetric division and remain to the outer of 335 
the embryo organization, while the remaining one third divide asymmetrically giving rise to 336 
one inner and one outer cell. Notably, such a 7:3 ratio of symmetric/asymmetric divisions is 337 
believed to occur during compaction (Morris et al., 2010). The observation that, before 338 
division, retraction of filopodia is followed by a change in cell shape from elongated to 339 
rounded, has inspired further experiments confirming a causal role of filopodia in the process 340 
of compaction. When filopodia were ablated by laser micromanipulation, the juxtaposed 341 
membranes of two adjacent cells retract immediately, indicating that filopodia impose 342 
mechanical forces between cells that can influence membrane tension and therefore cell 343 
shape. The same effect was not observed when adherens junctions were ablated (Fierro-344 
González et al., 2013).  345 
 346 
Molecular manipulations have confirmed a role for filopodia in determining cell elongation 347 
behaviours required by compaction. In effect, mouse blastomeres microinjected with E-348 
cadherin short interfering RNA (siRNA) form few filopodia, remain rounded and fail to 349 
integrate in a compacted structure formed by non-injected cells. Knock-down of α-catenin 350 
and β-catenin, which co-localise with E-cadherin in filopodia, also cause a drastic reduction 351 
in filopodia number and inability of the knocked-down blastomeres to elongate and compact 352 
(Fierro-González et al., 2013). Together, these findings confirm an instrumental role for E-353 
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cadherin and associated proteins in embryo compaction, while indicating filopodia, but not 354 
adherens junctions, as the prominent cell specialisation required for a change in cell shape 355 
from rounded to elongated.       356 
 357 
Collectively, this evidence indicates a critical role for cell adhesion in the process of 358 
compaction. However, cell adhesion appears to have other significant implications for the 359 
function of the morula and initiation of blastocyst formation. In particular, by preventing the 360 
free diffusion of membrane proteins, adherens junctions maintain the integrity of the baso-361 
lateral and apical membrane domains. Such a difference represents a prominent aspect of 362 
cell polarity. Differentiations in the composition and function of cell membrane domains are 363 
central for the mechanism of accumulation of intercellular fluid which leads to formation of 364 
the blastocoel. As a further consequence of the localisation and function of adherens 365 
junctions, the Na+/K+ ATPase system is localised only at the baso-lateral membrane domain 366 
of outer cells of mouse embryos (Watson and Kidder, 1988). By hydrolysation of one 367 
molecule of ATP, the enzyme transports three Na+ ions out of the cell, in exchange for two 368 
K+ ions. This allows the establishment of an ion concentration gradient between the 369 
intercellular spaces of the morula, which become enriched in Na+ ions, and the surrounding 370 
environment. As a result, and assisted by increased and coordinated expression of 371 
aquaporins (Barcroft et al., 2003), water flows unidirectionally from the exterior through the 372 
epithelial-like outer cells, accumulating extracellularly and thereby forming the blastocoel 373 
(Watson and Barcroft, 2001). Concomitantly at this stage, E-cadherin-dependent formation 374 
of tight junctions (zonulae occludens) creates a belt-like impermeable structure located at 375 
the upper-lateral sides of adjacent outer cells (Table 1). This specialisation of cell-to-cell 376 
contact contributes to the retention of water in the intercellular spaces of the embryo, as 377 
shown in the mouse, the human and other species (Eckert and Fleming, 2008). Live cell 378 
imaging used to study the development of mouse embryos has revealed that the creation of 379 
a barrier that seals the interior of the mouse embryo from the outside is assisted by an actin-380 
zippering mechanism. Before formation of the blastocoel, actin-rich rings form at the apical 381 
side of outer cells. These rings do not have contractile ability but instead expand in size and 382 
diameter until they reach cell-to-cell areas of contact. At this level, they interact with and 383 
stabilise cell junctions by recruiting the relevant components. This is followed by focused 384 
association with myosin II (Table 1). In this fashion, the newly formed actomyosin ring 385 
localised at the margins of adjacent cells produces the tension forces required for the 386 
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zippering mechanism that acts in coordination with cell junctions to seal the intercellular 387 
contact between outer cells (Zenker et al., 2018). 388 
 389 
Cellular arrangements in the nascent morula 390 
 391 
If indeed compaction, encompassing cell elongation and flattening, represents cellular 392 
"trickery" to accommodate inner and outer cells in the structure of the morula beyond the 8-393 
cell stage, it poses the question of how these two cell populations are generated in the first 394 
place. Collective evidence suggests that modalities by which inner and outer cell are 395 
generated are multiple and probably not mutually exclusive. One such modality, the first to 396 
be identified in studies on mouse embryo development, is based on two major elements, i.e. 397 
cell polarity and symmetry of cell division (Mihajlović and Bruce, 2017). As mentioned above, 398 
between the 8-cell and the 16-cell stage, blastomeres acquire a well-defined polarised 399 
organisation, with nuclear (Reeve and Kelly, 1983), cytoskeletal (Johnson and Maro, 1984; 400 
Houliston and Maro, 1989) and cell membrane components (Fleming and Pickering, 1985; 401 
Korotkevich et al., 2017) distributed differently in the baso-lateral (internal) and apical 402 
(external) domains. Blastomere polarisation was also observed in human embryos from the 403 
8-cell stage (Nikas et al., 1996). Different orientations of cleavage planes will therefore 404 
determine alternative destinies of daughter cells (Johnson and Ziomek, 1981a). Planes 405 
oriented parallel to the cell baso-apical axis will produce two symmetric daughter cells, both 406 
remaining in an external position and inheriting approximately the same polarised 407 
organisation of their progenitor cell. On the contrary, planes oriented orthogonally to the cell 408 
baso-apical axis will generate two asymmetric cells, one external cell inheriting the 409 
organisation and molecules of the apical domain and one internal cell characterised by baso-410 
lateral attributes of the mother cell. These two types of cell division are also referred to as 411 
conservative and differentiative, respectively, depending on whether they preserve and 412 
reproduce a pre-existing cellular status or generate diversity in the position (external or 413 
internal) and inheritance of cellular organisation (apical or baso-lateral) between daughter 414 
cells (Sutherland et al., 1990). Recent studies (Korotkevich et al., 2017) indicate that 415 
orientation of the cleavage plane at the 8-cell stage is not a random event, but rather seems 416 
regulated by innate cell contact-independent factors. For example, in isolated blastomeres 417 
of mouse embryos which already show signs of cell polarisation, the mitotic spindle aligns 418 
preferentially to the basal-apical axis producing asymmetric cells in more than 80% of cases 419 
(Korotkevich et al., 2017). In addition, experimental disruption of the apical domain in 420 
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isolated blastomere of 8-cell embryos is associated with a random spindle (and cleavage 421 
plan) orientation, suggesting that the cortical domain can regulate spindle positioning and 422 
ultimately symmetric or asymmetric division. This hypothesis is in line with micro-423 
transplantation experiments in which the cortical domain of polarised cells integrated in non-424 
polarised cells was able to induce asymmetric cell division (Korotkevich et al., 2017). The 425 
polarised cortical domain seems therefore not only necessary, but also sufficient to control 426 
the orientation of the cleavage plan and the occurrence of asymmetric division. 427 
Consequently, the geometry of cell division at the 8- 16-cell stage introduces a new 428 
structural dimension (inner-outer) in the multicellular organisation of the mouse embryo and 429 
creates diversity among blastomeres (Johnson, 2009). Notably, asymmetric division 430 
unequally redistributes cell fate determining factors (localised especially in the apical 431 
domain) in inner and outer cells, making them not only positionally, but also functionally, 432 
different (see below). Importantly, the frequency of symmetric and asymmetric divisions has 433 
implications for the relative proportion of inner and outer cells and, as a consequence, 434 
abundance of ICM and TE cells in the ensuing blastocyst (Bischoff et al., 2008). Studies on 435 
isolated blastomeres of 8-cell mouse embryos suggest that the probability by which 436 
symmetric and asymmetric divisions can occur may be an intrinsic cell characteristic at this 437 
stage (Johnson and Ziomek, 1981b), In particular, symmetric divisions, which preserve 438 
polarity in both daughter cells, are more likely to occur in blastomeres with larger apical 439 
domains (Pickering et al., 1988) and higher levels of expression of apical-specific 440 
determinants.  441 
 442 
More recent studies on cell allocation in the mouse embryo have shown that the geometry 443 
of cell division (symmetric/asymmetric) is not the exclusive, and perhaps not even the most 444 
important, modality by which the two populations of inner and outer cells are formed.  Such 445 
studies have been made possible by an advanced and highly sophisticated live imaging 446 
technique. This approach involves embryos that are microinjected with RNA encoding for a 447 
fluorescent protein (mCherry) targeting the cell membrane. The emitted fluorescence can 448 
be then detected by two-photon confocal microscopy and used to track cell positioning in 449 
4D at a high resolution, following analysis by a methodology referred to as computational 450 
membrane segmentation (Fierro-González et al., 2013). Mouse embryos at the 8 to 16-cell 451 
stage studied with this approach showed unexpected properties (Samarage et al., 2015). In 452 
the first place, it was observed that more than 80% of inner cells derive from symmetric 453 
divisions and that 60% of embryos produce inner cells without undergoing asymmetric 454 
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divisions. Therefore, asymmetric division, although important in the process of cell allocation 455 
as demonstrated by early studies, is not a frequent or “sine qua non” condition to determine 456 
the position of the first inner cells to be formed. Rather, computational membrane 457 
segmentation has revealed a different morphogenetic mechanism causing cell 458 
internalisation. Starting from the 12-cell stage, some cells undergo a well-defined change in 459 
shape that involves constriction of the apical portion and expansion of the baso-lateral 460 
domain, with a consequent gradual repositioning towards the geometrical centre of the 461 
embryo. Once positioned centrally, after the 16-cell stage these cells divide to increase their 462 
number, although more inner cells can be generated through the classical mechanism of 463 
asymmetric division (Samarage et al., 2015).  464 
 465 
Further observations clarified how apical constriction can occur in cells destined to 466 
internalisation (Samarage et al., 2015). In principle, cell constriction can result from different 467 
morphogenetic forces acting between adjacent cells, such as adhesion, involving E-468 
cadherin, and cortical tension, derived by contractility of actomyosin structures. In 8- to 16-469 
cell mouse embryos, E-cadherin is localised preferentially in the baso-lateral region of all 470 
cells, while no differences in its distribution are seen in the apical domain of constricting and 471 
non-constricting cells (Fierro-González et al., 2013). Modulation in cell-to-cell adhesion is 472 
therefore unlikely to generate apical constriction. On the contrary, myosin II, but not actin, 473 
distribution can differ between adjacent cells (Figure 1). In particular, Myosin II is more 474 
abundant at the borders between constricting and non-constricting cells, tending to 475 
accumulate as apical constriction progresses (Samarage et al., 2015). Micromanipulation 476 
experiments involving laser ablation of areas of the actomyosin organisation situated at the 477 
margins between constricting and non-constricting cells have produced data informing on 478 
directionality and magnitude of tensile interactions. Such information is consistent with a 479 
biomechanical model, according to which forces acting at the border of constricting cells 480 
promote their internalisation, while forces surrounding the same cells act against apical 481 
constriction and cell internalisation (Table 1). Myosin II is essential in this mechanism. This 482 
is shown by the evidence that, when Myosin II is experimentally downregulated in some, but 483 
not all, cells of an 8- to 16 cell embryo, control cells with normal levels of Myosin II fail to 484 
constrict and undergo internalisation if they are delimited by three or more knockdown cells. 485 
Therefore, tensile forces acting in non-constricting cells are also important for internalisation 486 
(Samarage et al., 2015).         487 
 488 
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The overall choreography by which cell shape changes to allow the accommodation of an 489 
adequate number and positioning of inner and outer cells in the growing mouse morula is 490 
therefore complex. Adherens junctions and filopodia drive modification of the cell shape from 491 
approximately spherical, until the 8-cell stage, to elongated and flattened at later stages to 492 
overcome the geometrical limitations imposed by the Newton’s kissing number. At the 493 
beginning of compaction, opposite tensile forces produced by actomyosin accumulation at 494 
the cell borders induce some cells to undergo apical constriction coupled to basal 495 
broadening. As a result of these changes, such cells reposition internally. At later stages of 496 
compaction, inner and outer cells are also generated by differential orientation of the 497 
cleavage planes by which outer cells divide, with planes oriented parallel or orthogonal to 498 
the cell basal-apical axis giving rise to only outer or both inner and outer cell, respectively. 499 
Finally, actomyosin rings localised at the areas of contact between outer cells generate 500 
tensile forces required to seal the barrier formed from adherens junctions, making it 501 
impermeable. This ultimately allows accumulation and retention of fluid in the blastocoel.  502 
 503 
Roles of cell positioning and polarity in cell fate determination 504 
 505 
Experimental removal and spatial rearrangements of blastomeres have shown that early 506 
mouse embryos are highly plastic. When one blastomere is removed from a 2-cell embryo, 507 
the remaining half embryo can develop to term without significant consequences. Also, 508 
blastomeres of 4- to 8-cell embryos, still morphologically and positionally identical, can be 509 
disassembled and reassembled to form chimaeric associations able to support normal pre- 510 
and postimplantation development (Morris et al., 2012). During the 8- to 16-cell interval, 511 
inner and outer cells are formed, developing preferentially into the ICM and TE 512 
compartments of the blastocyst, respectively. This could suggest a change in developmental 513 
rules by which cell potency is progressively restricted. While in general this concept is 514 
correct (Suwińska et al., 2008), the reality is more complex. Elegant cell disassociation-515 
reassociation experiments have revealed that all blastomeres of mouse 16-cell embryos 516 
maintain the ability to contribute to the formation of both the ICM and the TE (Ziomek and 517 
Johnson, 1982; Suwińska et al., 2008). Blastomeres of 32-cell embryos appear to have lost 518 
this plasticity, developing only into ICM or TE depending on whether they have an inner or 519 
outer origin, respectively (Suwińska et al., 2008). Therefore, under undisturbed conditions 520 
during the 8- 16-cell transition, blastomeres appear to have made ‘decisions’ about position 521 
and ultimate fate, but these seem not to be irreversible commitments to a specific lineage at 522 
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this stage. What make blastomeres different during the 8- 16-cell interval is their inner/outer 523 
position and apolar/polar symmetry. Historically, both these conditions have been proposed 524 
to cause cell determination at this stage (reviewed in Mihajlović and Bruce, 2017). According 525 
to one model, by definition, inner cells are totally engaged in cell-to-cell contacts throughout 526 
their surface, while outer cells have also cell-to-cell contact-free surfaces exposed to the 527 
surrounding environment. These two statuses are believed to coincide with different micro-528 
environmental cues that determine the ICM and TE cell fate, respectively. In the polarity 529 
model, at the 8-cell stage blastomeres become polarised acquiring a basolateral domain 530 
oriented towards the interior and an apical domain facing the exterior. Depending on whether 531 
cleavage occurs parallel or orthogonal to the baso-apical axis, daughter cells lose or 532 
preserve their polarity, respectively, and inherit differently distributed regulatory molecules 533 
that commit them into the ICM or TE pathway. The two models are not mutually exclusive, 534 
though, because predominantly inner cells are apolar and outer cells are polar. These 535 
concepts were already described in this review, but notably several more recent studies 536 
point toward an interplay between polarity, position and a third major regulator of cell fate, 537 
the Hippo signaling pathway. Hippo is a tumour-suppressor pathway described initially in 538 
Drosophila and conserved across species (Mihajlović and Bruce, 2017)(reviewed in Harvey 539 
et al., 2013). Its activation depends on several stimuli among which is, importantly in the 540 
case of embryos, cell contact. When Hippo is active, transcriptional co-activator proteins 541 
Yap (Yap1 and Wwtr1) are phosphorylated by Lats protein kinase. In its phosphorylated 542 
form, Yap is retained in the cytoplasmic compartment and degraded. By contrast, inactivity 543 
of Hippo allows nuclear localisation of unphosphorylated Yap. In the nucleus, Yap can bind 544 
several transcription factors, among which are TEA domain transcription factors (TEAD). 545 
Then, the binary complex TEAD-Yap targets several effector genes (Ota and Sasaki, 2008; 546 
Zhao et al., 2008) (Table 1). Clues that the TEAD and Hippo systems are involved in 547 
embryonic cell fate determination derives from experiments showing that in mutated TEAD4 548 
embryos, caudal-type homeoboxprotein-2 (Cdx2), which commit cells into the TE fate, is 549 
largely downregulated and all blastomeres acquire ICM characteristics (Yagi et al., 2007; 550 
Nishioka et al., 2008) (Table 1). However, because TEAD4 is ubiquitously expressed in the 551 
embryo, in normal development a modality must exist that prevents its action in blastomeres 552 
that develop into ICM. The key regulatory factor of this network in indeed Hippo (Figure 2) 553 
(Nishioka et al., 2009). Its signaling pathway is activated only in the inner cells, where Yap 554 
becomes phosphorylated, and so remains in the cytoplasm meaning that TEAD4 cannot 555 
trigger the TE pathway. At the same time, in the outer cells, unphosphorylated Yap can be 556 
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transported into the nucleus and activate TEAD4 (Hirate et al., 2012). Finally, TEAD4 directly 557 
promotes the transcription of TE-determining genes, such as the previously mentioned 558 
Cdx2, and GATA-binding protein 3 (Gata3) (Nishioka et al., 2009; Ralston et al., 2010) 559 
(Table 1).   560 
 561 
At this stage, cell polarity and position assume importance. In outer cells, polarity is imposed 562 
by mutual regulatory influences by which the Par3-Par6-aPKC (Par-aPCK) system promotes 563 
the organisation of the apical domain (Table 1), while Par1 induces the configuration of the 564 
baso-lateral domain (Suzuki and Ohno, 2006). Par-aPCK appears to have the ability to 565 
inhibit the Hippo pathway, which acts against the specification of TE characteristics. This is 566 
indicated by the finding that at the 32-cell stage in Par-aPCK-mutated embryos showing loss 567 
of polarity in outer cells, Hippo is activated and Yap remains localised in the cytoplasm in all 568 
blastomeres, not only in inner cells (Hirate et al., 2013). On another hand, Hippo signaling 569 
requires strong cell-cell adhesion, which is particularly enhanced in inner cells; this is 570 
confirmed by the fact that Hippo is not activated in dissociated blastomeres from polarity-571 
disrupted embryos irrespective of the original inner or outer cell position  (Hirate et al., 2013).  572 
 573 
In the human, studies on the role of Yap in cell determination are lacking. However, cell 574 
programming experiments showed that Yap is activated when embryonic fibroblasts are 575 
induced to become pluripotent stem cells, suggesting that the hippo regulatory pathway is 576 
involved in the expression of pluripotency (Lian et al., 2010). 577 
 578 
Some details on how, at the molecular level, polarity and cell adhesion interact to regulate 579 
Hippo activation are known (Figure 2). Hippo activation depends on angiomotin (Amot) 580 
proteins (Table 1). These regulatory proteins are also crucial for cell fate determination 581 
because their loss is sufficient to commit blastomeres into the TE fate irrespective of their 582 
position or polarity (Hirate et al., 2013; Leung and Zernicka-Goetz, 2013). Amot has a 583 
different intracellular distribution in inner and outer cells. In the former it is found associated 584 
with the adherens junctions throughout the membrane, while in the latter it is selectively 585 
localised at the apical domain (Hirate et al., 2013; Leung and Zernicka-Goetz, 2013). Amot 586 
also has binding activities which are differentially regulated in inner and outer cells. At the 587 
adherens junctions of inner cell, one region of the protein binds the cytoplasmic segment of 588 
E-cadherin and the junction-associated protein Nf2. Another subdomain of Amot has F-actin 589 
binding activity. In the same inner cells when the Amot-E-cadherin-Nf2 complex is formed, 590 
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phosphorylation of this site by Lats reduces the affinity for F-actin, promotes interaction with 591 
Lats itself and ultimately stimulates the ability of Lats to activate Hippo  (Hirate et al., 2013). 592 
In outer cells, polarisation generated by Par-aPKC sequesters Amot in the apical domain 593 
bound to F-actin and prevents the interaction of the same protein with E-cadherin at the 594 
level of adherens junctions. In this fashion, Amot is not phosphorylated by Lats and Hippo 595 
cannot be activated (Hirate et al., 2013). These conditions are permissive for a nuclear 596 
localisation of Yap and expression of TE-determining genes. Taken together, regulation of 597 
the Hippo signaling exemplifies how cell-cell adhesion, whose intensity depends on cell 598 
position and cell polarity, can influence call fate. This scenario, however, does not rule out 599 
that other factors can affect the Hippo-Yap pathway and ultimately cell fate. For example, in 600 
compacted mouse morulae, when biomechanical forces of outer blastomeres are 601 
experimentally weakened by knocking down the maternal myosin gene (Myh9), loss of cell 602 
contractility alone can lead to increased Yap phosphorylation and cytoplasmic localization. 603 
As a consequence of reduced intranuclear YAP presence, although such blastomeres 604 
remain external, they fail to express the TEAD-Yap-controlled genes that are responsible 605 
for the acquisition of TE characteristics (Maître et al., 2016). These experiments 606 
demonstrate an extreme integration of mechanical, positional and molecular cues in a single 607 
regulative network of cell fate determination. 608 
 609 
Molecular control of cell fate determination 610 
 611 
As described, Hippo signaling is a major regulatory mechanism which ultimately prevents 612 
expression of transcription factors that elicit the TE phenotype. However, several other 613 
questions concern the pathways that promote the specification of the TE and ICM lineages 614 
and establish mutual regulatory loops. Notably, decisions on cell fate are not necessarily 615 
made at the same time by the cells of the same compartment, making the understanding of 616 
regulatory networks particularly arduous. In addition, the large majority of data have been 617 
generated in the mouse model (see below), while information concerning the human 618 
embryos remains scant.  619 
 620 
TE specification 621 
 622 
As discussed above, Cdx2 is a crucial component for specification of TE characteristics. In 623 
the mouse 8-cell stage embryo, this regulator is expressed only in some blastomeres but as 624 
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the morula forms, it is found in a higher proportion of cells, to become expressed in outer 625 
cells of the morula and finally in elements of the TE (Jedrusik et al., 2008; Ralston and 626 
Rossant, 2008). Cdx2 -/- is embryonic lethal, due to the inability to form a TE.  Embryos 627 
begin to cavitate but the blastocoel do not form properly because outer cells do not acquire 628 
their typical epithelial phenotype and fail to form a selective barrier which is instrumental for 629 
inward transport of water and expansion of the embryo (Strumpf et al., 2005). In the absence 630 
of Cdx2 expression, a lack of epithelial characteristics is associated with specific molecular 631 
features, such as repression of Eomesodermin (Eomes) and Hand1, while ICM-determining 632 
genes are expressed ectopically (Strumpf et al., 2005). Eomes is a T-box-specific factor 633 
(Ciruna and Rossant, 1999). In null mutants, its absence coincides with the inability of 634 
embryos to develop a functional TE. This occurs in association with normal levels of Cdx2 635 
while Hand1 and P11, typical of epithelial differentiation, are undetectable (Strumpf et al., 636 
2005). Combined, these data suggest that the relative position of Eomes in the pathway that 637 
specifies the TE fate is downstream of Cdx2 and upstream of more terminal markers of TE 638 
differentiation. Another key regulator of TE formation is the zinc-finger transcription factor 639 
Gata3. Loss of function of this factor, through RNAi action, leads to a phenotype very similar 640 
to Cdx2 null mutants, in which blastocyst formation is impeded and development arrests at 641 
the blastocyst stage (Ralston et al., 2010). While there is consensus on the opinion that 642 
Gata3 is not governed by the Hippo pathway, the question of the hierarchical position with 643 
respect to Cdx2 is more controversial. However, a comparable temporal pattern of 644 
expression between Gata3 and Cdx2 suggest that the two regulators act in parallel (Ralston 645 
and Rossant, 2008), with no upstream influence of one over the other. Indeed, Gata3 is co-646 
expressed with Cdx2 already at the 8-cell stage and is found in TE, but not ICM cells, at the 647 
blastocyst stage (Ralston et al., 2010).  648 
 649 
ICM specification 650 
 651 
As the inner cells commit to their lineage, they must not only not express TE characteristics 652 
as an effect of hippo activation, but also, they must initiate the ICM pathway. In such cells, 653 
the master regulatory factor is the octamer-binding transcription factor 3/4 (Oct4, also known 654 
as Pou5f1) (Table 1). Oct4 positively regulates gene transcription by recognising the 655 
sequence ATGCAAAT situated in the promoters and enhancer regions of several genes 656 
(Schöler et al., 1990). While its expression is observed throughout preimplantation 657 
development, as the embryo develops its presence becomes restricted to the ICM. Oct4 658 
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appears downregulated in embryonic stem cells following differentiation induced by 659 
leukaemia inhibitory factor (LIF) (Palmieri et al., 1994), while its absence in Oct4 -/- mutant 660 
embryos does not prevent decidualisation but causes peri-implantation death (Nichols et al., 661 
1998). This factor is therefore considered instrumental for pluripotency. Other factors 662 
contribute to pluripotency of the ICM and are differentially regulated in a cell- and stage-663 
specific fashion. For example, in the mouse, Nanog (Chambers et al., 2003) is expressed in 664 
the inner cells of the morula and becomes restricted to the epiblast of the ICM in the 665 
blastocyst, from which the embryo proper derives (Chambers et al., 2003). Indeed, 666 
reprogramming experiments of somatic cells into induced pluripotent stem cells illustrate the 667 
critical importance of both Oct4 and Nanog in maintaining pluripotency (Takahashi and 668 
Yamanaka, 2006; Okita et al., 2007). 669 
 670 
The binding domain-containing family of transcription factors, Sox2, is a member of the High 671 
Mobility Group (HMG) protein family that is associated with maintenance of pluripotency in 672 
the embryo (Table 1). It is detectable throughout mouse preimplantation development, from 673 
the zygote until the morula stage, when it disappears in the cells that will form the TE  (Avilion 674 
et al., 2003). The observations that Sox2 -/- embryos have an unchanged pattern of protein 675 
expression and that Sox2 mRNA starts to be produced from the morula stage indicate that 676 
this factor is accumulated in the oocyte during oogenesis (Avilion et al., 2003). Sox2 appears 677 
crucial for ICM and in particular the epiblast at the time of implantation (Avilion et al., 2003). 678 
Furthermore, and interaction between Sox2 and Oct4 appears essential for the expression 679 
of downstream pluripotency genes, such as Fgf4 (Ambrosetti et al., 1997), Utf1 (Okuda et 680 
al., 1998) and Nanog (Rodda et al., 2005) (Table 1). Again, in the human, the timing of 681 
expression may differ; indeed, nuclear localization of Sox2 was observed only from the 682 
compacted morula stage, i.e. much later than in the mouse embryo (Cauffman et al., 2009). 683 
 684 
Mutual negative regulation 685 
 686 
Several lines of evidence converge towards a model involving mutual interaction at the 687 
intracellular level between the ICM and TE regulatory systems. Indeed, Cdx2 knockout 688 
mouse embryos are unable to promote positive regulation of TE specific genes such as 689 
Eomes and Hand1 in outer cells, but instead express Oct4 and Nanog, which are typically 690 
associated with inner cells. At the molecular level, this cross-regulation is explained by the 691 
fact that at the blastocyst stage Cdx2 and SWI/SNF chromatin remodelling factor co-operate 692 
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to bind the promoter region of Oct4 in cells that will develop into TE, thus inhibiting the action 693 
of this pluripotency factor.  This replicates a scheme observed in other types of epithelial 694 
cells (Wang et al., 2010).       695 
 696 
There are also hints of an inverse, mutual regulation between the Cdx2 and Oct4 pathways. 697 
Indeed, in embryonic stem cells, Oct4 was found to interact with Cdk1. The two proteins 698 
form a complex that is required to repress the transcription of Cdx2 (Li et al., 2012). 699 
Therefore, in the mouse, not only do the Cdx2 and Oct4 regulatory pathways specify the TE 700 
and ICM cell fates, respectively, but also are involved in an elegant interplay of mutual 701 
regulation in which one represses the other in its own embryonic compartment. Consistent 702 
with the mouse embryo, in the human at the 8-cell stage, Oct4 and Nanog are initially 703 
expressed in all blastomeres; afterwards their localization remains limited to the ICM 704 
(Kimber et al., 2008; Niakan et al., 2012). By contrast, human embryos show a different 705 
temporal pattern of Cdx2 expression. In fact, this regulator is detectable only after formation 706 
of the blastocoel and is initially co-expressed with Oct4 (Niakan et al., 2012). It seems, 707 
therefore, that specification of the two cell lines occurs significantly later than in the mouse 708 
and does not necessarily require the Oct4/Cdx2 antagonism. This opens the possibility that 709 
the fate of human blastomeres can remain plastic until relatively advanced stages of 710 
development. Indeed, human outer cells from compacted morulae or early blastocysts can 711 
contribute to formation of the ICM if experimentally repositioned inside the embryo (De 712 
Paepe et al., 2013) . Furthermore, after isolation and reaggregation, human outer cells are 713 
able to reconstitute an embryo able to cavitate and form an ICM (De Paepe et al., 2013). 714 
Therefore, while mouse and human development share some common features of cell fate 715 
determination, further studies are warranted to ascertain possible interspecies differences. 716 
 717 
The morula stage in clinical embryology 718 
 719 
Embryo selection and transfer at the morula stage 720 
 721 
Clinical data on the reproductive performance of day 4 embryos are scarce. In clinical IVF, 722 
embryos are usually transferred in the uterus at early cleavage (days 2/3) or blastocyst (days 723 
5/6) stages. Much less commonly, they are replaced on day 4 when they are expected to 724 
have reached the morula stage, owing in part to the challenges described above. 725 
Furthermore, where such embryos are used, they will often be transferred together with day 726 
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3 or day 5 embryos, making the association between embryonic stage and ability to implant 727 
and develop to term unachievable. However, there is isolated evidence that embryo transfer 728 
(ET) can be successfully implemented on day 4. In the late nineties, preliminary reports 729 
indicated that morula stage embryos could be used for ET following blastomere biopsy on 730 
day 3 in preimplantation genetic testing (PGT) cycles (Grifo et al., 1998; Gianaroli et al., 731 
1999). In one of the few specific studies carried out on the morula stage, Tao et al. (2002) 732 
compared retrospectively the relative clinical performance of day 3 and day 4 embryos. In 733 
all cases, day 4 ET were associated with higher implantation and pregnancy rates, 734 
suggesting that culture to day 4 could offer better chances for embryo selection compared 735 
to day 3. A prospective randomised study published several years later and including 350 736 
couples (Pantos et al., 2008) showed that day 4 ET was associated with implantation and 737 
clinical  pregnancy rates that were comparable to day 3 ET (22.0 vs. 21.0 and 49.7% vs. 738 
45.3%, respectively). A further retrospective analysis (Skorupski et al., 2007) claimed that 739 
the transfer of day 4 embryos was compatible with high rates of implantation (45% to 34%) 740 
and live birth (55% to 33%) across a large spectrum of female age (≤34 to 40 years). 741 
However, the absence of a control group and scoring criteria, as well as the fact that some 742 
of the embryos had undergone assisted hatching, means that these data need careful 743 
interpretation. The clinical outcome of day 4 and day 5 ET was the object of another 744 
retrospective study (Feil et al., 2008). This analysis adopted a single embryo transfer (SET) 745 
approach and reported comparable overall ongoing pregnancy rates between day 4 and day 746 
5 transfer (38.7% and 32.1%, respectively). In addition, sub-analysis of the day 4 group 747 
revealed that morulae entirely or partially compacted, and otherwise normal, implanted with 748 
comparable rates (40.0% and 37.1%, respectively); however, in cases where partial 749 
compaction was associated with large vacuoles and extensive fragmentation, the 750 
implantation rate dropped dramatically. Thus, day 4 embryos at the morula stage can be 751 
discriminated morphologically and developmentally to some degree and, in the best-case 752 
scenario, appear to have implantation rates comparable to that achieved by day 5 transfers. 753 
Such conclusions are supported by a further retrospective study by Kang et al., (2012). For 754 
all major clinical outcomes, i.e. pregnancy rate (51.5% vs. 51.8%), implantation rate (52.3% 755 
vs. 52.5%) and live birth rate (39.2% vs. 44.7%), results were comparable between morula 756 
and day 5 ET, respectively, although the miscarriage rate tended to be higher in the day 4 757 
group. Together, these data suggest that ET of morulae on day 4 can be contemplated as 758 
an option in case of intense laboratory workload and necessity to redistribute ETs more 759 
uniformly over consecutive days.  760 
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 761 
A recent report specifically focused on the predictive value of morphology of day 4 embryos 762 
(Fabozzi et al., 2015). Embryos were considered at the morula stage if showing at least 14 763 
cells and scored according to four morphological classes (A-D, best-worst), depending on a 764 
combination of the degrees of compaction and integrity. Out of 393 embryos, the proportions 765 
of grade A-D morulae were 47.84%, 26.72%, 20.36% and 5.09%, respectively. The degree 766 
of compaction and integrity was positively associated with the blastocyst formation rate 767 
which was 87.2%, 63.8%, 41.3%, and 15.0% for the A-D classes, respectively. Importantly, 768 
this classification system was found to be a better predictor of blastocyst formation and 769 
quality compared with a conventional grading system performed on day 3. Overall, these 770 
data confirm previous reports suggesting that the scoring systems based on degree of 771 
compaction and integrity of day 4 embryos have the ability to predict the rate and quality of 772 
blastocyst formation (Ebner et al., 2009; Ivec et al., 2011).  773 
 774 
The use of morula stage embryos for preimplantation genetic testing 775 
 776 
Over the course of the last decade, PGT has undergone major changes. Progress in embryo 777 
culture and cryopreservation have shifted the preference for the time of embryo biopsy from 778 
day 3 (6-8 cell stage) to day 5 or 6 (blastocyst stage). This means that more cells are 779 
available for analysis (3-10 instead of 1-2) and, in general, embryos appear more resilient 780 
to the biopsy procedure. However, Zakharova et al. (2014) reported on embryo biopsies 781 
performed on 709 day 4 morulae from 215 PGT cycles. To achieve loosening of intercellular 782 
contacts, compacted morulae were exposed to a Ca2+-free medium. Three to seven 783 
blastomeres were biopsied from each embryo and analysed by fluorescent in-situ 784 
hybridization (FISH). After return to standard medium containing Ca2+, more than 90% of 785 
biopsied embryos reached the blastocyst stage by day 6. In an impressive range of 786 
endpoints, including postnatal follow up, no differences were apparent between the PGT 787 
and non-PGT groups. Therefore, the authors concluded that embryo biopsy is technically 788 
feasible and safe to be carried out at the compacted morula stage. Although encouraging, 789 
caution must be exercised, since the relatively small numbers of embryos from a single-790 
centre study are unlikely to offer solid conclusions on the safely of the day 4 approach. 791 
Concerns derive not only from the possible impact of removal of 3-7 cells from an embryo 792 
usually formed from 12-32 blastomeres, but also from potential undefined physiological 793 
effects arising from the disruption, as we have illustrated above, of highly complex and 794 
Coticchio et al., “The enigmatic morula”  
 26 
important morphogenetic events occurring at the morula stage. Thus, exposure to Ca2+-free 795 
medium, functional ablation of intercellular contacts and consequent reversion of cell shape 796 
from elongated to spherical, although transient, could potentially perturb embryo physiology 797 
with long-term developmental consequences. Nonetheless, embryo biopsy at the morula 798 
stage remains an interesting option, implicating advantages such as i) the recovery of a 799 
higher number of cells compared to day 3 biopsy, ii) the possibility to have one full day for 800 
chromosome analysis and therefore perform fresh ET of unaffected embryos on day 5, and 801 
iii) the recovery of intact biopsied cells, whose integrity is amenable to FISH, in cases where 802 
this analytical method is preferable.  803 
 804 
Cryopreservation of human morulae 805 
 806 
Cryopreservation at the morula stage has been reported in numerous studies conducted in 807 
animal models, including mouse, rat, cow, pig and goat. Therefore, it appears to be 808 
technically possible. However, evidence from animal studies cannot be directly applied to 809 
human IVF. Membrane permeability to the various cryoprotectants, on which successful 810 
cryopreservation depends, occurs by simple diffusion or via specific channels (aquaporins) 811 
according to kinetics that vary from stage to stage often in a species-specific fashion. Early 812 
experiments suggested that human blastocysts vitrified using fine plastic capillaries as 813 
storage devices gave acceptable rates of survival (Cremades, 2004). Recent progress in 814 
vitrification has allowed improvement in survival rates of both intact and biopsied morulae 815 
(92.0% and 87.5%, respectively) (Zhang et al., 2009). Isolated cases of healthy live births 816 
(one twin and one single) were  also reported after the transfer of compacted morulae 817 
cryopreserved by slow freezing (Tao et al., 2001). In a larger case series, 54 day 4 morulae 818 
were warmed after vitrification; 38 embryos survived to 24 hours after thawing, while 30 819 
developed to the blastocyst stage. In 18 ETs, implantation and birth rates for ET were 20.0% 820 
(6/30) and 27.8% (5/18), respectively (Vanderzwalmen et al., 2002). Therefore, while 821 
cryopreservation at the morula stage can be applied, the limited available data suggest a 822 
reduced efficacy compared with cryopreservation at the cleavage or blastocyst stage. Again 823 
however, caution should be exercised as this is an underinvestigated area of treatment. 824 
 825 
Emerging data from TLM   826 
 827 
Timing of the morula stage  828 
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 829 
For decades, the morula has been described as characteristic of day 4, but little data was 830 
available on the specific timing of cleavage events beyond the 8-cell stage or the dynamics 831 
of the process of compaction (ESHRE Atlas of Human Embryology). Isolated reports 832 
indicated that starting compaction ‘early’ was associated with a higher implantation potential 833 
(Skiadas et al., 2006), although the precise timing of initiation of this process was not 834 
described. 835 
 836 
The introduction of TLM has provided new opportunities to observe the morphokinetics of 837 
the morula stage. In one of the first TLM studies describing the morula stage, Campbell et 838 
al., (2013) reported the median time of start of compaction in euploid embryos was 79.7 839 
hours post ICSI, a value similar to that of embryos affected by a single aneuploidy (80.7 840 
hours), but significantly different to that of embryos carrying multiple aneuploidies (85.1 841 
hours). Median times of full morula formation in the three study groups were not statistically 842 
different (83.5, 87.9 and 88.2 hours, respectively). Another study investigated the formation 843 
of the fully compacted morula in embryos of PGT cases, reporting mean times of 94.4 and 844 
95.3 hours in euploid and aneuploid embryos, respectively (Minasi et al., 2016). Times of 845 
full compaction appears different in the two studies, although it should be noted that they 846 
were reported using different parameters (median and mean, respectively). In a study 847 
specifically focussed on stage of compaction, Iwata et al. (2014) found that compaction can 848 
occur at any stage between the 4- and the 16-cell stage, although the majority of embryos 849 
initiate compaction at the 8-cell stage or later. In such embryos, almost half go on to form 850 
good quality blastocysts, while embryos starting compaction before the 8-cell stage form 851 
good blastocysts in less than 20% of cases. Interestingly, early compacting embryos appear 852 
to be characterised by cell cycle anomalies, like multinucleation caused by cytokinesis 853 
failure (Iwata et al., 2014).  854 
 855 
Technically, the determination of the time of full compaction is challenging because of its 856 
dynamic nature, occurring over several hours. Therefore, significant intra- and inter-operator 857 
variability cannot be excluded. Nonetheless, it is realistic that time differences between 858 
studies, at the morula and all developmental stages, can reflect intrinsic differences between 859 
cohorts of embryos and/or extrinsic influences, such as culture conditions. Indeed, while 860 
mean times of formation of fully compacted morulae are very similar in males and females 861 
embryos (91.2 and 91.9 hours, respectively) (Bronet et al., 2015), embryos from 862 
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overweight/obese women have an overall faster developmental kinetics. This is also 863 
reflected in times of morula formation 17 hours shorter than women of normal weight (Leary 864 
et al., 2015). Likewise, in another study, it was shown that embryos undergoing repeated 865 
contractions and expansions during blastocyst formation, a phenomenon indicated as a 866 
negative marker of implantation potential, achieve full compaction approximately 5 hours 867 
earlier (80.9 vs. 86.3 hours, respectively) compared with those that do not exhibit cyclical 868 
contractions/expansions (Marcos et al., 2015). Laboratory manipulations can also impact 869 
the morula stage. Indeed, an analysis carried out in embryos produced in PGT cycles 870 
described that day 3 embryos of at least 8 cells and subject to removal of 1-2 blastomeres 871 
progressed to the morula stage with a 5-hour delay and implanted at a lower rate compared 872 
with embryos of a control group (Bar-El et al., 2016). These findings are consistent with a 873 
previous study reported by Kirkegaard et al. (2011). Notwithstanding such limitations, the 874 
time of compaction alone appears to be associated with embryo implantation. This notion 875 
derives from a recent study showing that in a selected population of embryos full compaction 876 
in accomplished 14 hours earlier in those that implant (86.4 vs. 100.3 hours, respectively) 877 
(Motato et al., 2016).  878 
 879 
Morphokinetics and chromosomal status of the morula 880 
Data from a recent investigation (Lagalla et al., 2017) suggest that the morula stage could 881 
be an important checkpoint for embryo quality during preimplantation development and that 882 
the process of compaction could be involved in mechanisms of self-correction. The study 883 
confirmed that diverse cleavage anomalies (e.g. direct cleavage of one cell into three, rapid 884 
cleavage, reverse cleavage) were associated with a 50% reduction in the chances of an 885 
embryo developing into a good quality blastocyst. Interestingly, the study also showed that 886 
blastocysts derived from such abnormally cleaving embryos exhibited a higher rate of 887 
euploidy compared with blastocysts developed from embryos without cleavage anomalies 888 
(75.0% vs, 49.2% respectively). Even more interestingly, it was found that all euploid 889 
blastocysts derived from abnormally cleaving embryos were characterised by the 890 
phenomenon of partial compaction. Partial compaction was observed also in embryos with 891 
no apparent cleavage anomalies, but at a much lower rate. Taken together, these findings 892 
suggest that, on one hand, blastomeres that have become aneuploid as a consequence of 893 
cleavage anomalies (e.g. direct cleavage) may in some cases prevent development to 894 
blastocyst. On the other hand, it might be possible that such aneuploid blastomeres are 895 
excluded at compaction, with a rescue of the original condition of euploidy of the embryo as 896 
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a whole. The latter hypothesis appears to be confirmed by comparative chromosome 897 
analysis of cells excluded from compaction. In the majority of cases, in the same embryo 898 
the chromosome constitution of these cells was more affected by segregation errors 899 
compared with cells of the trophectoderm, or they could not be analysed due to extensive 900 
DNA degradation, a hallmark of apoptosis often triggered in response to complex 901 
aneuploidy. Therefore, it is plausible to propose that during compaction, aneuploid cells are 902 
excluded from the embryos allowing a restoration of euploidy. This is in line with the well-903 
established notion that mosaicism is more frequent in earlier stages of development than at 904 
the blastocyst stage. If true, this suggests a startling critical role for the morula in terms of 905 
embryo rescue and elimination of mosaicism, as well as the more widely-described functions 906 
relating to morphogenetic events and determination of cell fate. The notion of the existence 907 
of mechanisms of self-correction during preimplantation development is also emerging from 908 
other observations. For example, a study on embryos displaying direct unequal cleavage 909 
(i.e. division of one cell into three or more daughter cells) indicates that extrusion from the 910 
compacted morula of blastomeres affected by such a cleavage anomaly is strongly 911 
associated with the formation of good quality blastocysts (Zhan et al., 2016).  Such 912 
information might be of crucial relevance in the application of PGT at the morula stage. 913 
 914 
A plea for more research on the morula stage and compaction process 915 
 916 
Recent investigations confirm the necessity of intensifying research efforts on the morula 917 
stage. Data from Mayer et al (2018) described the phenomenon of late onset of cell 918 
vacuolisation at the morula stage. In particular, they reported that the implantation ability of 919 
good quality blastocysts is significantly reduced in case of formation of vacuoles at the 920 
morula stage. The morula stage also appears relevant to the management of slow-growing 921 
embryos. In fact, Tannus et al. (2018) observed that embryos reaching the morula stage on 922 
early day 5 and achieving the blastocyst stage on day 6 can implant with higher frequency 923 
if cryopreserved and transferred in a frozen embryo replacement, instead of being used 924 
fresh, confirming the importance of endometrial receptivity and synchronisation. Even more 925 
intriguing information seems to derive from detailed observation of the mechanism of 926 
compaction and elimination of presumably abnormal cell from the mass that then organises 927 
itself into blastocyst. In a preliminary report, Lagalla and colleagues (2018) proposed the 928 
existence of two distinct mechanisms of cell elimination resulting in partial compaction: a) 929 
exclusion of cells from the outset, before the beginning of compaction, or b) extrusion of 930 
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cells following their initial involvement in the compaction process. Interestingly, in partially 931 
compacted embryos, exclusion was found to occur more frequently in embryos of younger 932 
women, while the opposite was observed in case of extrusion. This finding, together with 933 
the recently reported differences in chromosome constitution between the embryo and cells 934 
eliminated during compaction (Lagalla et al., 2017), is suggestive of the morula stage as an 935 
important checkpoint stage during formation of a viable blastocyst. However, research in 936 
clinical embryology alone is unlikely to have the capacity to reveal the intimate secrets of 937 
the morula stage. Strategic collaboration with other disciplines and approaches will be 938 
crucial to ensure progress in this field. Being a dynamic process and extremely difficult to 939 
observe even with the aid of TLM, the morula stage could be amenable to investigation by 940 
exploiting machine learning approaches, which has already found application to predict 941 
embryo implantation ability at the blastocyst stage (Zaninovic et al., 2018). Further progress 942 
could derive from the analysis of extruded/excluded cells to reveal their cellular and 943 
molecular constitution and gain more in-depth insights on possible mechanisms of self-944 
correction. Live cell imaging, especially if developed in a truly non-invasive fashion, could 945 
also give a crucial impulse to research on the morula stage. Three-dimensional modelling 946 
approaches have already begun to reveal how cell internalisation, and therefore formation 947 
of the two main cell lineages, occurs only when differences in cell surface contractility 948 
exceed a predictable threshold (Maître et al., 2016). Molecular, cellular and metabolic 949 
analysis of spent media exposed to embryos of different developmental stages could shed 950 




The morula stage and the associated process of compaction have received relatively little 955 
attention in ART due to their highly dynamic nature combined with the ambiguous criteria of 956 
morphological classification. Morula stage embryos therefore remain scarcely integrated in 957 
the mainstream ART procedures, such as embryo quality assessment, ET, cryopreservation 958 
and embryo biopsy. This is in striking conflict with the importance that the construction of 959 
the morula has for preimplantation development and indeed the entire developmental 960 
process. For example, during the temporal span of the morula stage, newly expressed 961 
genes of the embryonic genome mediate the transition from a low-activity, low-energy 962 
metabolic state characterising the early cleavage stages to a more active glucose-based 963 
aerobic capacity required for the formation and expansion of the blastocyst (Leese, 2012). 964 
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From a developmental standpoint, the morula stage is when the first crucial cell-fate decision 965 
is taken, whereby blastomeres commit themselves to contribute to either the ICM or TE 966 
compartment (Mihajlović and Bruce, 2017). As early as the 1980s, positional information 967 
(internal or external localisation) was recognised as a determining factor for the 968 
establishment of an ICM or TE cell fate (Fleming, 1987). Early studies also suggested that, 969 
starting from the 8-10 cell stage, differential intracellular distribution of cell determinants 970 
cooperates with the geometry of cleavage planes to generate functional diversity between 971 
internal and external cells (Johnson and Ziomek, 1981a; 1981b). These notions remain valid 972 
today. However, recent studies, aided by extraordinary progress in live cell imaging 973 
techniques, have expanded our understanding of the biology of the morula (Table 1). We 974 
now know that compaction is assisted not only by junctional structures, but also by fine and 975 
dynamic regulation of specialised cellular projections, filopodia  (Fierro-González et al., 976 
2013). We have also learnt that generation of inner and outer cells occurs not only as a 977 
consequence of alternative orientation of cleavage planes, but also as an effect of 978 
differences in cortical tension between adjacent outer blastomeres. In addition, new 979 
information has revealed the crucial role of an actin-zippering mechanism in ensuring 980 
intercellular sealing and establishing a permeability barrier required by the process of 981 
blastocoel expansion. New light has also been shed on the mutually regulated pathways of 982 
gene expression that commit cells into distinct developmental destinies (Jedrusik, 2015). 983 
Although obtained in the mouse model, such a wealth of information has reignited interest 984 
in the specific merit of the morula stage for clinical embryology. Information on possible 985 
influences of in-vitro culture on developmental decisions taken at the morula stage are 986 
lacking in human ART. Indeed, recent morphokinetic data suggest that compaction could 987 
represent an opportunity to sense chromosomal anomalies in individual blastomeres and 988 
implement self-correction mechanisms aimed at excluding abnormal cells from the 989 
developing embryo (Lagalla et al., 2017). Overall, such a knowledge casts new light on this 990 
crucial developmental stage. It also indicates new avenues for future research in 991 
preimplantation development in the context of clinical embryology. 992 
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Figure 1. Forces that shape blastomeres and secure sealing of intercellular spaces at 1348 
the morula stage. A) Flows of cortical cytoplasm and a network of polar microtubules 1349 
cooperate to generate a ring of actin in the apical domain of outer cells. This ring expands 1350 
reaching the cell boundaries, recruits myosin II, becomes contractile and allows cell shape 1351 
remodelling. B) At cell boundaries, expanded actin rings cooperate with tight and adherens 1352 
junctions to achieve intercellular zippering and sealing to finally assist accumulation of 1353 
intercellular fluid and formation of the blastocoel. 1354 
 1355 
 1356 





Figure 2. Example of integration of positional, polarity and molecular cues to achieve 1360 
differential gene expression and determination of alternative cell fates. In inner cells 1361 
(in green), Amot is associated with the adherens junctions throughout the cell membrane 1362 
and has reduced activity for F-actin. This condition promotes interaction with and 1363 
phosphorylation by Lats and ultimately activation of the Hippo regulatory pathway, which 1364 
prevents intranuclear localisation of Yap and expression of TE determining genes. In outer 1365 
cells (in blue), polarisation generated by Par-aPKC sequesters Amot in the apical domain 1366 
bound to F-actin and prevents the interaction of the same protein with E-cadherin at the 1367 
level of adherens junctions. In this fashion, Amot is not phosphorylated by Lats and Hippo 1368 
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Contribute to the formation of 
adherens junctions (zonulae 
adherens), which ensure mutual 
lateral adhesion between epithelial 
cells, thus contributing to the 
maintenance of epithelial cell polarity 
Vestweber et al., 1987; 
Haegel et al., 1995; 
Riethmacher et al., 1995; 
Campbell et al., 1997; 
Torres et al., 1997; Perez-






Contribute to the organization and 
function of filopodia, which extend 
between adjacent blastomeres and 
determine cell flattening during 
compaction 
Fierro-Gonzáles et al., 
2013. 
E-cadherin Intervenes in the formation of tight 
junctions (zonulae occludens), which 
create belt-like impermeable 
structures located at the upper-lateral 
sides of adjacent outer cells 
Eckert and Fleming, 2008. 
Actin 
Myosin II 
Co-operate to lead to the formation of 
an actomyosin ring localized at the 
margins of adjacent cells. This ring 
produces the tension forces required 
for the zippering mechanism that acts 
in coordination with cell junctions to 
seal the intercellular contact between 
outer cells 
Zenker et al., 2018. 
Myosin II Generates tensile forces at cell 
borders and constriction of the apical 
domain, by which blastomeres are 
internalized 




Co-operate in the formation of a 
regulatory mechanism involving 
signaling of Hippo for the 
phosphorylation and consequent 
cytoplasmic localization of Yap. 
Absence of nuclear localization of 
Yap prevents the activation of the 
transcription regulator TEAD. 
Inactivation of Hippo leads to 
localization of dephosphorylated Yap 
in the nucleus and activation of TEAD 
Ota and Sakaki, 2008; Zhao 
et al., 2018; reviewed in 
Harvey et al., 2013; 
Nishioka et al., 2009; Hirate 
et al., 2012. 
TEAD Upon activation by unphosphorylated 
Yap, TEAD initiates the transcription 
of several effector genes, among 
which those that determine the 
trophectoderm cell fate (e.g. Cdx2 
and Gata3)  
Yagi et al. 2007; Nishioka et 
al., 2008; Nishioka et al., 




Interact mutually to establish apical 
(Par-aPCK) and baso-lateral domains 
in outer cells 
Suzuki and Ohno, 2006. 




Inhibit the Hippo pathway, which acts 
against the specification of 
trophectoderm characteristics 




Cooperate to activate Hippo Hirate et al., 2013; Leung 
and Zernicka-Goetz;  
Cdx2 
Gata3 
Once expressed as an effect of 
positive regulation by TEAD, induce 
the expression of trophectoderm 
characteristics. 
Jedrusik 2008; Ralston and 





Act as apical regulators for the 
maintenance of cell pluripotency 
Chambers et al. 2003; 
Takahashi and Yamanata, 





Are regulated by Oct4 and Sox2, 
contributing to the preservation of 
pluripotency 
Ambrosetti et al., 1997; 
Okuda et al., 1998; 
Cauffman et al., 2009. 
 1381 
 1382 




Table 1. Schematic description of function of proteins in key developmental 1387 
processes that characterise the morula stage. These include compaction, intercellular 1388 
sealing to allow blastocoel formation, positioning of inner and outer cells, establishment of 1389 
cell polarity and cell fate determination. 1390 
 1391 
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